Last reviewed · How we verify

NCT07171749

Prevalence of Hemolytic Uremic Syndrome (HUS) in Pediatrics

Not yet recruiting Last updated 15 September 2025
What this trial tests

trial in Prevalence of Hemolytic Uremic Syndrome in 50 participants. Not yet recruiting.

Timeline
1 October 2025
Primary endpoint
30 September 2026
30 October 2026

Quick facts

Lead sponsorAssiut University
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment50
Start date1 October 2025
Primary completion30 September 2026
Estimated completion30 October 2026

Conditions studied

Sponsor

Assiut University

Who can join

Adults 1 Day to 18, any sex, with Prevalence of Hemolytic Uremic Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To determine the prevalence of hemolytic uremic syndrome (HUS) among pediatric patients admitted to Assiut University Children's Hospital, and to describe the demographic, clinical, and laboratory characteristics of the affected population.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07171749.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing